Fabricio Pamplona

PROFESSIONAL SUMMARY (LAST 5 YEARS)
Consultant for Pharmaceutical development of Cannabis-based products and Head of Science of Entourage Phytolab (2015-2018), a pharmaceutical startup that led the process of developing Cannabis- based medical products in Brazil. Former Scientific Researcher at the D'Or Institute of Research and Education (IDOR) (2011-2015), a private-owned enterprise lead by the major chain of health care in Brazil (Rede D'Or), including hospitals, clinical analyses laboratories and imaging laboratories. Principal investigator for translational scientific studies of the endocannabinoid system physiology published in the Annals of the US National Academy of Science (PNAS) and currently being developed into an innovative diagnostic tool for Alzheimer’s disease.

SCIENTIFIC TRACK-RECORD
Awarded PhD scientist with 15 years of translational and clinical research in the field of Psychopharmacology, with international experience in the Max Planck Institute of Psychiatry (Germany). and 50 articles published in international peer-reviewed journals and over 1800 citations (H-index 23, with 7 papers over 100 citations). Successfully lead collaborative international research projects among Brazil, France and Germany. Speaker at the main events on cannabinoid research, including International Cannabinoid Research Society (ICRS), Gordon Research Conference on Endocannabinoids (Switzerland), ExpoCannabis (Uruguai) and CannMed at the Harvard Medical School (USA) among others in translational neuroscience.

ENTREPRENEURIAL TRACK-RECORD
Former partner of one consulting company for pre-clinical and clinical development of pharmaceutical products (Trial Pharma 2010-2011) with major Brazilian pharmaceutical companies as clients (Aché, Biolab, EMS, Eurofarma, etc). Founder of a technology startup in education technology for Life Sciences and Health (Mind the Graph 2014-current), where led product development and successfully launched the product internationally.

[Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.]